Delivery Order SPE2DR25D2014-SPE2DR26FA8X4
Award Date 3/16/26
Potential Completion Date 3/17/26
Potential Value $4.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 11, 2026, for Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $4,187.60 under firm fixed pricing. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle running through December 2026 that provides global pharmaceutical and medical supply support to military healthcare...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for Gvoke HypoOpen 2-pack 1 mg/0.2 ml auto-injectors, with a ceiling value of $2,404.86. Place of performance is Conshohocken, PA. The order is firm fixed price, non-competitive set-aside, and carries an ultimate completion date of March 17, 2026. The order is issued under the parent IDC held by Cencora, Inc. (AmerisourceBergen's parent organization) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gvoke HypoGel 2-pack 1 mg/0.2 ml auto-injectors, a glucagon emergency treatment product used for severe hypoglycemia. The contract is valued at $3,567.70 and represents a firm fixed-price delivery order with a completion date of September 26, 2025. This award is non-set-aside and was competitively awarded. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $21,248.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoGen 2-pack auto-injectors (1 mg/0.2 ml), with an ultimate completion date of September 5, 2025. This non-set-aside competitive award leverages AmerisourceBergen's comprehensive indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency issued a $21,350.20 delivery order to AmerisourceBergen Drug Corp on March 1, 2026, for Glucagon 1 mg emergency auto-injector supply with an ultimate completion date of March 2, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare systems globally. Place of performance is Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12,911.45 to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 20, 2026, for the supply of Gvoke HypopenG 2-pack auto-injectors (1 mg/0.2 ml). This is a firm fixed-price, non-competitive set-aside contract with a completion date of January 21, 2026, and performance at the awardee's Conshohocken, Pennsylvania facility. The delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,639.17 for GVOKE HypoOpen 2-pack auto-injectors (1 mg/0.2 mL) on October 30, 2025, with completion scheduled for October 31, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside provisions and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gvoke HypoGlucagon (1-pack, 1 mg/0.2 mL) under a firm fixed-price contract valued at $2,043.63. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery/Indefinite Quantity (IDIQ) prime vendor agreement with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The award was made...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $16,139.59. This is a firm fixed price delivery order with an ultimate completion date of April 25, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,109.11 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Gvoke HypoPen 1-Pack 1 mg/0.2 mL auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is a child contract executed...